Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies.

PubWeight™: 5.78‹?› | Rank: Top 1%

🔗 View Article (PMC 1358006)

Published in Ann Surg on September 01, 1989


T E Starzl1, S Todo, A Tzakis, L Podesta, L Mieles, A Demetris, L Teperman, R Selby, W Stevenson, A Stieber

Author Affiliations

1: Department of Surgery, University Health Center of Pittsburgh, Pennsylvania.

Articles citing this

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54

Upper abdominal exenteration with liver replacement: a modification of the "cluster" procedure. Transplant Proc (1990) 2.40

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation (1992) 2.20

Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg (1998) 1.99

Use of FK 506 in pediatric patients. Transplant Proc (1991) 1.77

Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg (1998) 1.72

Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology (1997) 1.36

Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg (2004) 1.35

Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg (1997) 1.29

Liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 1.09

Treatment of upper abdominal malignancies with organ cluster procedures. Clin Transplant (1990) 1.07

Inhibition of liver, kidney, and intestine regeneration by rapamycin. Transplantation (1992) 1.00

Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen--an update. Transplantation (1991) 1.00

Themes of liver transplantation. Hepatology (2010) 0.98

The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg (1992) 0.97

In vivo effect of FK506 on human pancreatic islets. Transplantation (1991) 0.89

Human islet allotransplantation under FK 506. Transplant Proc (1991) 0.89

Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemother Pharmacol (1992) 0.88

Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg (1992) 0.85

Is surgery still the optimal treatment for stage I non-small cell lung cancer? Transl Lung Cancer Res (2016) 0.83

Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol (2013) 0.83

Science, specialization, and the American Surgical Association. Ann Surg (1997) 0.78

Combined en bloc liver/pancreas transplantation in two different patients. World J Gastroenterol (2009) 0.78

Intestinal transplantation. Annu Rev Med (1994) 0.78

Glucose homeostasis is regulated by donor islets in xenografts. Transplant Proc (1992) 0.76

Human islet allotransplantation in 18 diabetic patients. Transplant Proc (1992) 0.76

Liver transplantation for malignancy. Br J Cancer (1991) 0.75

Effect of FK 506 on function of human islets of Langerhans. Transplant Proc (1991) 0.75

World's longest surviving liver-pancreas recipient. Liver Transpl (2007) 0.75

Outcome of human islet isolation and allotransplantation in 20 consecutive cases. Diabetes Nutr Metab (1992) 0.75

[Multiple transplantation of abdominal organs]. Bull Acad Natl Med (1992) 0.75

Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine. Organogenesis (2014) 0.75

Multivisceral and small bowel transplantation at shiraz organ transplant center. Int J Organ Transplant Med (2014) 0.75

Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. Transplant Proc (1992) 0.75

Pancreas procurement from multiorgan donors for islet trasplantation. Diabetes Nutr Metab (1992) 0.75

Articles cited by this

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Transplantation of small bowel in the rat: technical and immunological considerations. Surgery (1971) 5.05

An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Homotransplantation of multiple visceral organs. Am J Surg (1962) 4.28

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg (1983) 3.15

A review of adult and pediatric post-transplant liver pathology. Pathol Annu (1987) 2.62

The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35

Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med (1984) 2.25

Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease. JAMA (1989) 2.10

Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg (1989) 1.67

Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation (1988) 1.52

Hepatotrophic substances. Prog Liver Dis (1979) 1.39

"Erythrocytosis" in renal transplantation patients treated with cyclosporine. Transplant Proc (1988) 1.02

Effect of somatostatin analogue (SMS201-995) on cyclosporine levels. Transplantation (1987) 1.01

Effect of a cyclic hexapeptide analog (L363,586) of somatostatin on the function of pancreas grafts in dogs. J Surg Res (1985) 0.99

Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Interference with cyclosporine immunosuppression. Transplantation (1987) 0.98

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Kidney transplantation under FK 506. JAMA (1990) 7.45

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Liver from bone marrow in humans. Hepatology (2000) 4.10

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54


Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85

The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79


The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68

Sex ratio associated with timing of insemination and length of the follicular phase in planned and unplanned pregnancies during use of natural family planning. Hum Reprod (1998) 2.67

Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc (1990) 2.60

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Upper abdominal exenteration with liver replacement: a modification of the "cluster" procedure. Transplant Proc (1990) 2.40

Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39

Liver transplantation across ABO blood groups. Surgery (1986) 2.39

Toxicology of FK-506 in the Lewis rat. Transplant Proc (1987) 2.37

The antibody crossmatch in liver transplantation. Surgery (1986) 2.33

The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32

Liver transplantation for type IV glycogen storage disease. N Engl J Med (1991) 2.31

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31

FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29

Animal research in liver transplantation with special reference to the dog. Semin Liver Dis (1985) 2.28

The hepatotropic influence of cyclosporine. Surgery (1990) 2.27

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20

Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc (1990) 2.15

Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14

Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest (1991) 2.13

FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13

Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10

The side effects of FK 506 in humans. Transplant Proc (1990) 2.08

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol (1997) 2.05

Should the cement mantle around the femoral component be thick or thin? J Bone Joint Surg Br (2003) 2.05

Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet (1995) 2.04

The use of interferon for the treatment of viral hepatitis in pediatric liver transplant recipients. J Okla State Med Assoc (1995) 2.02